UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050843
Receipt number R000057935
Scientific Title Efficacy of Nursing Program to Support Lifestyle with Exercise and Rest for Fatigue in Patients After Neoadjuvant Chemotherapy for Breast Cancer
Date of disclosure of the study information 2023/04/14
Last modified on 2023/04/13 16:33:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of Nursing Program to Support Lifestyle with Exercise and Rest for Fatigue in Patients After Neoadjuvant Chemotherapy for Breast Cancer

Acronym

Nursing Program to Support Lifestyle with Exercise and Rest for Fatigue in Patients After Neoadjuvant Chemotherapy for Breast Cancer

Scientific Title

Efficacy of Nursing Program to Support Lifestyle with Exercise and Rest for Fatigue in Patients After Neoadjuvant Chemotherapy for Breast Cancer

Scientific Title:Acronym

Effectiveness of Nursing Program to Support Lifestyle with Exercise and Rest for Fatigue in Patients After Neoadjuvant Chemotherapy for Breast Cancer

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study aims to evaluate the effectiveness of a nursing program to support a lifestyle incorporating exercise and rest for fatigue in patients after neoadjuvant chemotherapy for breast cancer.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cancer Fatigue Scale
Evaluate at the beginning of the intervention, at 6 weeks, at 12 weeks, and 4 weeks after the end of the intervention.

Key secondary outcomes

Quality of life: EORTC QLQ-C30
Physical Activity: Global Physical Activity Questionnaire, Steps, Exercise time
Sleep condition: Pittsburgh Sleep Quality Index, Sleeping time
Evaluate at the beginning of the intervention, at 6 weeks, at 12 weeks, and 4 weeks after the end of the intervention.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Patients in the intervention group work with the nurse to develop a plan for a life that incorporates exercise and rest (breathing method). The nurse will periodically check on the implementation of the plan for 12 weeks and provide support for continuation.

Interventions/Control_2

Patients in the comparison group receive usual care.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1)More than 4 weeks but less than 12 months after completion of neoadjuvant chemotherapy for breast cancer and surgery.
2)Those who have cancer-related fatigue.
3)Stage III or less and no metastasis.
4)No experience with cancer treatment other than breast cancer.
5)Those who have a smartphone.
6)Have no exercise habits and no regular relaxation and are interested in participating in the study.
7)Have no cognitive decline.
8)Those who are judged by the physician in charge to be capable of participating in the research.


Key exclusion criteria

1)Has a history or current history of cardiovascular disease, respiratory disease, diabetes mellitus, or psychiatric disease.
2)Difficulty in exercise due to musculoskeletal problems.
3)Severe side effects associated with breast cancer treatment.

Target sample size

44


Research contact person

Name of lead principal investigator

1st name Risa
Middle name
Last name TASHIRO

Organization

Chiba University

Division name

Graduate School of Nursing

Zip code

260-8672

Address

1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8672 JAPAN

TEL

043-226-2771

Email

rtashiro@chiba-u.jp


Public contact

Name of contact person

1st name Risa
Middle name
Last name TASHIRO

Organization

Chiba University

Division name

Graduate School of Nursing

Zip code

260-8672

Address

1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8672 JAPAN

TEL

043-226-2771

Homepage URL


Email

rtashiro@chiba-u.jp


Sponsor or person

Institute

Chiba University

Institute

Department

Personal name



Funding Source

Organization

YAMAJI FUMIKO NURSING RESEARCH FUND

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee, Graduate School of Nursing, Chiba University

Address

1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8672 JAPAN

Tel

043-226-2462

Email

kango-rinri@chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 01 Month 10 Day

Date of IRB

2023 Year 01 Month 10 Day

Anticipated trial start date

2023 Year 03 Month 01 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 04 Month 14 Day

Last modified on

2023 Year 04 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057935


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name